Regenerate your own Kidney

Bioelectric Stimulation + Micro Infusion Pump + KC-15 Composition for


Learn MoreClinical Study

Focused on total
kidney regeneration

(1) Bioelectric stimulator +
(2) micro infusion pump +
(3) fifteen component KC-15 kidney regeneration
composition for kidney regeneration.

Repairing kidneys the way they are built in the first place with bioelectric signaling, stem cells, growth factors, exosomes, micro RNAS and matrix!

Unlocking the body’s own healing potential!

KidneyCell Files Patent for Precise Bioelectric Klotho Increase Up to 430%

KidneyCell Announces Issuance U.S. Patent No. 10,646,644 May 12th, 2020 with 20 Years Patent Life for Bioelectric and Biologics Based Kidney Regeneration

KidneyCell Announces Launch of New Bioelectric Stimulation Study to Attempt to Reverse Kidney Failure

This clinical study demonstrates for the first time that bioelectric stimulation is able to reduce DNA damage in blood of CKF patients.

Neuromuscular Electrical Stimulation in Chronic Kidney Failure: A Systematic Review and Meta-analysis

661,000 Americans are in kidney failure.

30,000,000+ Americans have chronic kidney disease.

Patients have to wait up to 10 years for kidney transplant

There are many side effects associated with kidney transplantations which cost up to $200,000. Side effects include tubular fibrosis. Anti-rejection drugs cost $75,000 to $100,000 annually.
There is no effective cure aside from kidney transplantation, too few donors, and a high morbidity and mortality associated with long-term dialysis. Approximately 5-7% of hospitalized patients experience acute kidney injury, a leading cause of mortality in institutionalized settings.

Kidney Disease Statistics

12 Hours

A typical in-center hemodialysis patient spends 12 hours a week attached to a machine

93% Patients

Among patients ages 18-54 years old at the start of dialysis, 93% were classified as disabled


Each year, more than 100,000 Americans begin hemodialysis as a result of kidney failure

40 Million

40 Million adult Americans are currently classified as having chronic kidney disease

13 Patients

Every day 13 patients die waiting for a kidney transplant


Of Stage 4 CKD patients, 48% were unaware of their severe CKD

3.5 Times

African-Americans are 3.5x more likely to develop kidney failure

1.5 Times

Hispanics are 1.5x more likely to develop kidney failure

Leonhardt MicroStimulator II

Leonhardt Implantable Micro Stimulator Option

Harnessing the regeneration potential of bioelectric signaling,
stem cells and support factors!

The KidneyCell team is developing a product intended for total kidney regeneration utilizing a combination of bioelectric signaling controlled release or regeneration promoting proteins, including a stem cell homing signal, and a re-fillable micro infusion pump that is re-filled daily or weekly with a fifteen component composition comprised of stem cells, growth factors, exosomes, micro RNAs, selected alkaloids, amniotic fluid, PRF, nutrient engineering hydrogel and kidney matrix.

The core founders of KidneyCell have been working on regeneration therapies since the 1980s and bring deep experience into this development. KidneyCell has assembled an all-star team of scientists, bioengineers, clinicians and advisors to advance this development forward.

CAUTION Disclaimer and Warning: Products described on this web site are in early stage development and are not yet proven safe or effective in statistically significant controlled clinical studies. Any statement or phrases implying efficacy or safety in any form are considered modified by “intended to” or “designed to”. Investigational use only in countries where investigation is permitted by law and proper filings have been made and appropriate regulatory clearances have been granted. Any use of the product(s) must be in an authorized clinical study with institutional review board (ethics committee) approval and proper patient consent procedures followed. For other countries product is only available for laboratory investigation by credentialed institutions and investigators with proper clearances with a research agreement in place with a study sponsor. NOT AVAILABLE FOR SALE.